ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $57.8M

      Shares

      1.72M

      % of Portfolio

      0.98%

      Average Buy Price

      $30.7

      Avg closing price
      Price range

      7 Jefferies Group VICI Properties Trades

      Jefferies Group acquired 1.72M VICI Properties shares worth $57.8M. That's 0.98% of their equity portfolio (15th largest holding). The first VICI Properties trade was made in Q4 2022. Since then Jefferies Group bought shares three more times and sold shares on three occasions. The stake costed the investor $53M, netting the investor a gain of 9.0% so far.

      Avg closing price
      Price range
      Sold 37.4% shares (-1.03M shares) Q2 2025
      Avg closing price $31.83
      Price range $29.41 - $32.97
      New holding (+2.75M shares) Q1 2025
      Avg closing price $30.75
      Price range $28.22 - $32.68
      Sold -8.42k shares Q1 2024
      Avg closing price $30.01
      Price range $28.82 - $32.66
      New holding (+8.42k shares) Q4 2023
      Avg closing price $29.37
      Price range $27.18 - $32.18
      Sold -36.3k shares Q2 2023
      Avg closing price $32.08
      Price range $30.28 - $33.94
      Increased shares by 77.4% (+15.8k shares) Q1 2023
      Avg closing price $33.08
      Price range $30.06 - $34.65
      New holding (+20.4k shares) Q4 2022
      Avg closing price $32.13
      Price range $29.40 - $34.39

      News about VICI Properties Inc and Jefferies Group

      The Top 3 Real Estate Stocks to Buy in April 2024

      The Top 3 Real Estate Stocks to Buy in April 2024

      Stocks specializing in real estate, such as real estate investment trusts (REITs), are a great option for investors seeking exposure to the real estate marke...

      InvestorPlace InvestorPlace, over 1 year ago
      Earnings Scheduled For May 1, 2023

      Earnings Scheduled For May 1, 2023

      Companies Reporting Before The Bell ? TG Therapeutics (NASDAQ: TGTX ) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. ?...

      Benzinga Benzinga, over 2 years ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×